Nazanin Tatari

830 total citations
19 papers, 263 citations indexed

About

Nazanin Tatari is a scholar working on Oncology, Immunology and Molecular Biology. According to data from OpenAlex, Nazanin Tatari has authored 19 papers receiving a total of 263 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Oncology, 10 papers in Immunology and 9 papers in Molecular Biology. Recurrent topics in Nazanin Tatari's work include CAR-T cell therapy research (6 papers), Glioma Diagnosis and Treatment (6 papers) and Immunotherapy and Immune Responses (5 papers). Nazanin Tatari is often cited by papers focused on CAR-T cell therapy research (6 papers), Glioma Diagnosis and Treatment (6 papers) and Immunotherapy and Immune Responses (5 papers). Nazanin Tatari collaborates with scholars based in Canada, Switzerland and United States. Nazanin Tatari's co-authors include Hesam Movassagh, Abdelilah S. Gounni, Lianyu Shan, Sheila K. Singh, Chitra Venugopal, Neil Savage, Latifa Koussih, Tamra E. Werbowetski‐Ogilvie, Vijay Ramaswamy and Marc R. Del Bigio and has published in prestigious journals such as Proceedings of the National Academy of Sciences, The Journal of Immunology and Cancer Research.

In The Last Decade

Nazanin Tatari

18 papers receiving 263 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Nazanin Tatari Canada 10 122 74 68 63 56 19 263
Caroline Bérenguer France 10 207 1.7× 66 0.9× 41 0.6× 40 0.6× 95 1.7× 12 366
Arend H. Sikkema Netherlands 9 196 1.6× 50 0.7× 72 1.1× 39 0.6× 46 0.8× 12 340
Lisa Haas Austria 5 131 1.1× 140 1.9× 126 1.9× 55 0.9× 26 0.5× 5 355
Vincenza Lombari Italy 8 179 1.5× 75 1.0× 63 0.9× 66 1.0× 65 1.2× 9 378
Hye-Min Jeon South Korea 8 184 1.5× 99 1.3× 46 0.7× 95 1.5× 19 0.3× 11 325
Alberto Visioli Italy 6 184 1.5× 96 1.3× 27 0.4× 76 1.2× 97 1.7× 6 326
Berta Segura‐Collar Spain 11 156 1.3× 91 1.2× 91 1.3× 114 1.8× 17 0.3× 20 327
Wenqi Du China 12 208 1.7× 74 1.0× 30 0.4× 23 0.4× 43 0.8× 20 323
Janani Sundaresan United States 7 293 2.4× 42 0.6× 61 0.9× 43 0.7× 27 0.5× 12 445
Fabrizio Giani Italy 6 188 1.5× 93 1.3× 25 0.4× 93 1.5× 116 2.1× 6 330

Countries citing papers authored by Nazanin Tatari

Since Specialization
Citations

This map shows the geographic impact of Nazanin Tatari's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nazanin Tatari with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nazanin Tatari more than expected).

Fields of papers citing papers by Nazanin Tatari

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nazanin Tatari. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nazanin Tatari. The network helps show where Nazanin Tatari may publish in the future.

Co-authorship network of co-authors of Nazanin Tatari

This figure shows the co-authorship network connecting the top 25 collaborators of Nazanin Tatari. A scholar is included among the top collaborators of Nazanin Tatari based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nazanin Tatari. Nazanin Tatari is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Mikolajewicz, Nicholas, Nazanin Tatari, Jiarun Wei, et al.. (2024). Functional profiling of murine glioma models highlights targetable immune evasion phenotypes. Acta Neuropathologica. 148(1). 74–74.
2.
Roux, Julien, Alicia Buck, Nazanin Tatari, et al.. (2023). Targeting the Siglec–sialic acid axis promotes antitumor immune responses in preclinical models of glioblastoma. Science Translational Medicine. 15(705). eadf5302–eadf5302. 47 indexed citations
3.
Chokshi, Chirayu, Agata Kieliszek, Nazanin Tatari, et al.. (2023). An HLA-G/SPAG9/STAT3 axis promotes brain metastases. Proceedings of the National Academy of Sciences. 120(8). e2205247120–e2205247120. 8 indexed citations
4.
Tatari, Nazanin, Andreas Zingg, Viviane J. Tschan, et al.. (2023). P06.15.B IMMUNOTHERAPEUTIC TARGETING OF FIBROBLAST ACTIVATION PROTEIN (FAP) IN TREATMENT REFRACTORY GLIOBLASTOMA USING NOVEL CAR-T CELL THERAPY. Neuro-Oncology. 25(Supplement_2). ii49–ii49. 1 indexed citations
5.
Martins, Tomás A., Nazanin Tatari, Sabrina A. Hogan, et al.. (2023). EXTH-44. ENHANCING GLIOBLASTOMA CLEARANCE: EMPOWERING ANTI-EGFRVIII CAR T CELLS WITH A PARACRINE SIRPΓ-DERIVED CD47 BLOCKER. Neuro-Oncology. 25(Supplement_5). v234–v234. 1 indexed citations
6.
Tatari, Nazanin, Neil Savage, Dillon McKenna, et al.. (2022). Real-time evaluation of a hydrogel delivery vehicle for cancer immunotherapeutics within embedded spheroid cultures. Journal of Controlled Release. 348. 386–396. 5 indexed citations
7.
Tatari, Nazanin, Xiaoyu Zhang, Shawn C. Chafe, et al.. (2022). Dual Antigen T Cell Engagers Targeting CA9 as an Effective Immunotherapeutic Modality for Targeting CA9 in Solid Tumors. Frontiers in Immunology. 13. 905768–905768. 9 indexed citations
8.
Chokshi, Chirayu, et al.. (2021). Advances in Immunotherapy for Adult Glioblastoma. Cancers. 13(14). 3400–3400. 12 indexed citations
9.
Tatari, Nazanin, et al.. (2020). Preclinical Testing of CAR T Cells in a Patient-Derived Xenograft Model of Glioblastoma. STAR Protocols. 1(3). 100174–100174. 6 indexed citations
10.
Chokshi, Chirayu, Agata Kieliszek, Nazanin Tatari, et al.. (2020). 47. UNCOVERING A NOVEL ROLE FOR HLA-G IN BRAIN METASTASES. Neuro-Oncology Advances. 2(Supplement_2). ii9–ii9. 1 indexed citations
11.
Tatari, Nazanin, Hesam Movassagh, Lianyu Shan, Latifa Koussih, & Abdelilah S. Gounni. (2019). Semaphorin 3E Inhibits House Dust Mite–Induced Angiogenesis in a Mouse Model of Allergic Asthma. American Journal Of Pathology. 189(4). 762–772. 17 indexed citations
12.
Manoranjan, Branavan, Chirayu Chokshi, Chitra Venugopal, et al.. (2019). A CD133-AKT-Wnt signaling axis drives glioblastoma brain tumor-initiating cells. Oncogene. 39(7). 1590–1599. 31 indexed citations
13.
Seyfrid, Mathieu, et al.. (2018). In Vitro Self-Renewal Assays for Brain Tumor Stem Cells. Methods in molecular biology. 1869. 79–84. 6 indexed citations
14.
Tatari, Nazanin, et al.. (2018). Embryonic Stem Cell Models of Human Brain Tumors. Methods in molecular biology. 1869. 127–142. 1 indexed citations
15.
Tatari, Nazanin, Agnes Fresnoza, Christopher J. Porter, et al.. (2018). CD271+ Cells Are Diagnostic and Prognostic and Exhibit Elevated MAPK Activity in SHH Medulloblastoma. Cancer Research. 78(16). 4745–4759. 23 indexed citations
16.
Tatari, Nazanin, Gareth Palidwor, Vijay Ramaswamy, et al.. (2018). Characterization of a novel OTX2‐driven stem cell program in Group 3 and Group 4 medulloblastoma. Molecular Oncology. 12(4). 495–513. 15 indexed citations
17.
Movassagh, Hesam, Saravanan Nandagopal, Nazanin Tatari, et al.. (2016). Chemorepellent Semaphorin 3E Negatively Regulates Neutrophil Migration In Vitro and In Vivo. The Journal of Immunology. 198(3). 1023–1033. 32 indexed citations
18.
Movassagh, Hesam, Nazanin Tatari, Lianyu Shan, et al.. (2016). Human airway smooth muscle cell proliferation from asthmatics is negatively regulated by semaphorin3A. Oncotarget. 7(49). 80238–80251. 27 indexed citations
19.
Aiken, Christopher, Robyn L. McClelland, Nazanin Tatari, et al.. (2015). Characterization of novel biomarkers in selecting for subtype specific medulloblastoma phenotypes. Oncotarget. 6(36). 38881–38900. 21 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Caroline Bérenguer Breakdown of academic impact, for papers by Arend H. Sikkema Breakdown of academic impact, for papers by Lisa Haas Breakdown of academic impact, for papers by Vincenza Lombari Breakdown of academic impact, for papers by Hye-Min Jeon Breakdown of academic impact, for papers by Alberto Visioli Breakdown of academic impact, for papers by Berta Segura‐Collar Breakdown of academic impact, for papers by Wenqi Du Breakdown of academic impact, for papers by Janani Sundaresan Breakdown of academic impact, for papers by Fabrizio Giani
Rankless by CCL
2026